Skip to content
★ Sign in to follow
SI

Shanghai INT Medical Instruments Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong

HK·Mcap HK$8.4BHealth Care

2 insiders bought shares over the last 90 days, the latest by Liang Dongke, filed 13 Oct 2026.

Cluster: 2 buyers in 30 days

Shanghai INT Medical Instruments Co., Ltd. - H Shares: what insiders have been doing

Every trade that managers of Shanghai INT Medical Instruments Co., Ltd. - H Shares disclose to HKEX is tracked on this page. The company sits in the Health Care sector. From 22 October 2025 to 22 October 2026, the disclosure feed for Shanghai INT Medical Instruments Co., Ltd. - H Shares logged 4 filings by 2 insiders.

The flow runs one way only: 2 insiders bought (4 purchases) and nobody sold on the market. The amount is not disclosed for 4 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 senior executives.

The most recent open-market purchase was published on 13 October 2026, 26 days ago. The median gap between a trade and its publication by HKEX is 3 days. That lag is the time during which only the insider knows about the trade.

For context, the typical company on the same exchange (median of 1,314 companies) published 4 filings over the same period, against 4 filings here. The full history, which starts in 2026, counts 4 purchases against no sales.

For comparison within the same sector, see the insider buying recorded at UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
4 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Liang Dongke2 buys
Song Yuan2 buys

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 11,562 of 26,897 companies
55.2
score / 100
Value
40
Quality
71
FCF yld2.9%
Earn yld2.7%
EV/EBITDA23.7x
ROE11%
Gross mgn60%
Net mgn21%
Debt/EBITDA1.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$29.96
Analyst consensus
·
Income statement
RevenueHK$1.1B
Gross profitHK$636.8M60% margin
EBITDAHK$375.1M35% margin
Net incomeHK$218.8M19.2% margin
Valuation
PER (trailing)21.9x
P/Book2.0x
Beta0.03
Balance sheet & cash
Market capHK$8.4B
Total debtHK$716M
Free Cash FlowHK$233.5M
Debt / Equity25%
Profitability & ownership
ROE10.7%
ROA5.9%
% insiders71.7%
% institutions13.3%
Last declaration on 13 October 2026
Declarations4 total
  • ▲
    DirectorExecutives
    0HKEX
    1,823,000 sharesShareXHKGHKEX:DA20261013E00478
    Canonical exit: 10 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    1,823,000 sharesShareXHKGHKEX:DA20261013E00482
    Canonical exit: 10 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    11HKEX
    33,400 sharesShareXHKGHKEX:DA20260702E00373
    Canonical exit: 26 Sept 2026 (T+90)
  • ▲
    DirectorExecutives
    11HKEX
    33,400 sharesShareXHKGHKEX:DA20260702E00349
    Canonical exit: 26 Sept 2026 (T+90)

4 of 4 declarations

About Shanghai INT Medical Instruments Co., Ltd. - H Shares

Shanghai INT Medical Instruments Co., Ltd. is a company specializing in the manufacturing of medical instruments. It is listed on the stock market under the H Shares category.